Year: 2022

Correction: Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022.

Company announcement – No. 9 / 2022 Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for...

Diagnostic Wearable Medical Devices Market to grow at a CAGR of 15.09% by 2025 | Growing Demand for Early Diagnosis & Preventive Medicine to Boost Growth | Technavio

NEW YORK, March 10, 2022 /PRNewswire/ -- The diagnostic wearable medical devices market is fragmented and the vendors are deploying organic...

error: Content is protected !!